0000899243-17-010709.txt : 20170421
0000899243-17-010709.hdr.sgml : 20170421
20170421160526
ACCESSION NUMBER: 0000899243-17-010709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170419
FILED AS OF DATE: 20170421
DATE AS OF CHANGE: 20170421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palti Yoram
CENTRAL INDEX KEY: 0001654403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 17775937
MAIL ADDRESS:
STREET 1: 5 HET STREET
CITY: HAIFA
STATE: L3
ZIP: 3508504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-19
0
0001645113
Novocure Ltd
NVCR
0001654403
Palti Yoram
C/O NOVOCURE INC., 20 VALLEY STREAM PKWY
SUITE 300
MALVERN
PA
19355
1
1
0
0
Chief Technology Officer
Ordinary Shares
2017-04-19
4
S
0
4000
11.033
D
127825
D
Ordinary Shares
2017-04-20
4
S
0
4000
11.455
D
123825
D
On April 19, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $10.90 to $11.20. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On April 20, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Professor Palti, Professor Palti sold 4,000 shares in multiple trades at prices ranging from $11.15 to $11.55. The price reported above reflects the weighted average sale price. Professor Palti hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
By: /s/ Todd Longsworth Attorney in fact for Yoram Palti
2017-04-21